ClinicalTrials.govpublic full text
ACRYSOF® Restor Apodized Diffractive IOL Postmarket Evaluation of Clinical Outcomes and Life-Style Visual Performance RESTOR IOL SN60WF IOL (Control Group)
refractive assessment, restor iol versus conventional iol, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 967395
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.